Healthcare & Biotech
Rejuvenation Technologies Inc.
mRNA therapeutics to extend healthspan entering clinical trials
Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1…
- Therapeutics
- Anti-Aging
- Gene Therapy
- Website
- rejuvenationtech.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 2-10 people
- Founded
- 2018
- Demo
- 30 min demo
Similar companies
ParcelBioElevated mRNA for transformative medicines.
Uncommon TherapeuticsA Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Kopra BioGenetically engineered viruses that teach your immune system to kill…
FinalDoseProgrammable DNA drug destroying all cancers, unlocking 80% of targets
Promakhos TherapeuticsA therapeutics platform for curing inflammatory disorders
Humane GenomicsA platform to make artificial viruses as cancer therapeutics.
Gilgamesh PharmaceuticalsGilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
OpenBiomeA nonprofit stool bank enabling access to fecal transplants.